全新发布丨CHINET中国细菌耐药监测结果(2021年1-12月)

2022-02-14 胡付品 SIFIC感染视界

一睹为快~

2022年2月11日,复旦大学附属华山医院抗生素研究所胡付品教授整理的最新《CHINET中国细菌耐药监测结果(2021年1-12月)》在www.chinets.com发布。
  • 2021年,革兰阴性菌占71.4%,革兰阳性菌占28.6%。

  • 301917株临床分离菌在各类标本中的分布:呼吸道标本37.8%,尿液标本20.7%,血液标本14.4%,伤口脓液6.6%,其他无菌体液5.5%,脑脊液1.0%,生殖道分泌物1.0%,粪便标本1.2%,其他11.7%。

  • 排名前5位分离菌:大肠埃希菌18.96%、肺炎克雷伯菌14.12%、金葡菌8.93%、铜绿假单胞菌7.96%、鲍曼不动杆菌7.28%。

  • 甲氧西林耐药葡萄球菌中:MRSA占30%,MRSE占80.7%,其他MRCNS占77.7%。MRSA和MSSA中,未发现万古霉素、去甲万古霉素、利奈唑胺和替考拉宁耐药菌株。MRSE和MSSE中,未发现对万古霉素、去甲万古霉素和替加环素耐药菌株。MRCNS中,未发现对万古霉素和替加环素耐药菌株。

  • 肺炎克雷伯菌对亚胺培南耐药率23.1%,对美罗培南耐药率24.4%。49150株克雷伯菌属对硫酸黏菌素的耐药率最低仅为2.3%,替加环素3.9%,头孢他啶阿维巴坦7.4%。9879株碳青霉烯类耐药肺炎克雷伯菌对硫酸黏菌素的耐药率最低仅为5.3%,替加环素7.4%,头孢他啶阿维巴坦11.1%。

  • 肠杆菌属细菌对亚胺培南的耐药率为9.4%,对美罗培南耐药率为9.6%。10889株肠杆菌属细菌对硫酸黏菌素的耐药率仅为1.9%,替加环素为2.8%。

  • 铜绿假单胞菌对亚胺培南的耐药率为23%,对美罗培南耐药为18.9%。24035株铜绿假单胞菌对硫酸黏菌素的耐药率仅为2%,头孢他啶阿维巴坦为5.5%。5572株碳青霉烯类耐药铜绿假单胞菌对硫酸黏菌素的的耐药率仅为4.4%,头孢他啶阿维巴坦为13.9%。

  • 鲍曼不动杆菌对亚胺培南耐药率为71.5%,对美罗培南耐药率72.3%。26084株不动杆菌属对硫酸黏菌素的耐药率仅为1.6%,替加环素为2.5%。15166株碳青霉烯类耐药鲍曼不动杆菌对硫酸黏菌素的耐药率仅为0.9%,替加环素为3.6%。

  • 2021年CHINET中国细菌耐药监测结果显示:硫酸黏菌素对碳青霉烯类耐药肺炎克雷伯菌、铜绿假单胞菌、鲍曼不动杆菌高度敏感!

原文下载网址:http://www.chinets.com/Document#

图片

图片

图片

图片

图片

图片

图片

图片

图片

图片

图片

图片

图片

图片

图片

图片

图片

图片

图片

图片

图片

图片

图片

图片

图片

图片

图片

图片

图片

图片

图片

图片

图片

图片

图片

图片

图片

图片

图片

图片

图片

图片

图片

图片

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2069784, encodeId=45782069e84ff, content=<a href='/topic/show?id=c525804035a' target=_blank style='color:#2F92EE;'>#耐药监测#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80403, encryptionId=c525804035a, topicName=耐药监测)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=xinxin088, createdTime=Fri Feb 18 05:20:35 CST 2022, time=2022-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1734467, encodeId=2d991e344672c, content=<a href='/topic/show?id=d4f412668a4' target=_blank style='color:#2F92EE;'>#NET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12668, encryptionId=d4f412668a4, topicName=NET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ea033781210, createdName=canlab, createdTime=Tue Feb 22 00:20:35 CST 2022, time=2022-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1586918, encodeId=52271586918f6, content=<a href='/topic/show?id=e2d3e8130f4' target=_blank style='color:#2F92EE;'>#细菌耐药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78130, encryptionId=e2d3e8130f4, topicName=细菌耐药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=690d17392347, createdName=yilong5287548, createdTime=Wed Feb 16 13:20:35 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193619, encodeId=5487119361908, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dfcf5562063, createdName=ms2000001254384452, createdTime=Tue Feb 15 14:35:01 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193485, encodeId=fec31193485bb, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ae36495381, createdName=ms9000002100948639, createdTime=Tue Feb 15 09:08:36 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193463, encodeId=51dd1193463ec, content=2021年12月患者无明显诱因下出现发热,Tmax, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIrrxxDxnLic8t6EAs38Qfwo6H2h6JMleIgb9OSYf6LMnVDkQEqUXWoSDWboibjhOBI9SJDTXweqQIA/132, createdBy=50aa5321359, createdName=查查佳佳, createdTime=Tue Feb 15 08:07:26 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193455, encodeId=4f9811934552a, content=写得好,知识面广, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89ae6481716, createdName=ms3000000637975859, createdTime=Tue Feb 15 06:38:02 CST 2022, time=2022-02-15, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2069784, encodeId=45782069e84ff, content=<a href='/topic/show?id=c525804035a' target=_blank style='color:#2F92EE;'>#耐药监测#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80403, encryptionId=c525804035a, topicName=耐药监测)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=xinxin088, createdTime=Fri Feb 18 05:20:35 CST 2022, time=2022-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1734467, encodeId=2d991e344672c, content=<a href='/topic/show?id=d4f412668a4' target=_blank style='color:#2F92EE;'>#NET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12668, encryptionId=d4f412668a4, topicName=NET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ea033781210, createdName=canlab, createdTime=Tue Feb 22 00:20:35 CST 2022, time=2022-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1586918, encodeId=52271586918f6, content=<a href='/topic/show?id=e2d3e8130f4' target=_blank style='color:#2F92EE;'>#细菌耐药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78130, encryptionId=e2d3e8130f4, topicName=细菌耐药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=690d17392347, createdName=yilong5287548, createdTime=Wed Feb 16 13:20:35 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193619, encodeId=5487119361908, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dfcf5562063, createdName=ms2000001254384452, createdTime=Tue Feb 15 14:35:01 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193485, encodeId=fec31193485bb, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ae36495381, createdName=ms9000002100948639, createdTime=Tue Feb 15 09:08:36 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193463, encodeId=51dd1193463ec, content=2021年12月患者无明显诱因下出现发热,Tmax, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIrrxxDxnLic8t6EAs38Qfwo6H2h6JMleIgb9OSYf6LMnVDkQEqUXWoSDWboibjhOBI9SJDTXweqQIA/132, createdBy=50aa5321359, createdName=查查佳佳, createdTime=Tue Feb 15 08:07:26 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193455, encodeId=4f9811934552a, content=写得好,知识面广, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89ae6481716, createdName=ms3000000637975859, createdTime=Tue Feb 15 06:38:02 CST 2022, time=2022-02-15, status=1, ipAttribution=)]
    2022-02-22 canlab
  3. [GetPortalCommentsPageByObjectIdResponse(id=2069784, encodeId=45782069e84ff, content=<a href='/topic/show?id=c525804035a' target=_blank style='color:#2F92EE;'>#耐药监测#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80403, encryptionId=c525804035a, topicName=耐药监测)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=xinxin088, createdTime=Fri Feb 18 05:20:35 CST 2022, time=2022-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1734467, encodeId=2d991e344672c, content=<a href='/topic/show?id=d4f412668a4' target=_blank style='color:#2F92EE;'>#NET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12668, encryptionId=d4f412668a4, topicName=NET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ea033781210, createdName=canlab, createdTime=Tue Feb 22 00:20:35 CST 2022, time=2022-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1586918, encodeId=52271586918f6, content=<a href='/topic/show?id=e2d3e8130f4' target=_blank style='color:#2F92EE;'>#细菌耐药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78130, encryptionId=e2d3e8130f4, topicName=细菌耐药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=690d17392347, createdName=yilong5287548, createdTime=Wed Feb 16 13:20:35 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193619, encodeId=5487119361908, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dfcf5562063, createdName=ms2000001254384452, createdTime=Tue Feb 15 14:35:01 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193485, encodeId=fec31193485bb, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ae36495381, createdName=ms9000002100948639, createdTime=Tue Feb 15 09:08:36 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193463, encodeId=51dd1193463ec, content=2021年12月患者无明显诱因下出现发热,Tmax, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIrrxxDxnLic8t6EAs38Qfwo6H2h6JMleIgb9OSYf6LMnVDkQEqUXWoSDWboibjhOBI9SJDTXweqQIA/132, createdBy=50aa5321359, createdName=查查佳佳, createdTime=Tue Feb 15 08:07:26 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193455, encodeId=4f9811934552a, content=写得好,知识面广, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89ae6481716, createdName=ms3000000637975859, createdTime=Tue Feb 15 06:38:02 CST 2022, time=2022-02-15, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2069784, encodeId=45782069e84ff, content=<a href='/topic/show?id=c525804035a' target=_blank style='color:#2F92EE;'>#耐药监测#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80403, encryptionId=c525804035a, topicName=耐药监测)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=xinxin088, createdTime=Fri Feb 18 05:20:35 CST 2022, time=2022-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1734467, encodeId=2d991e344672c, content=<a href='/topic/show?id=d4f412668a4' target=_blank style='color:#2F92EE;'>#NET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12668, encryptionId=d4f412668a4, topicName=NET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ea033781210, createdName=canlab, createdTime=Tue Feb 22 00:20:35 CST 2022, time=2022-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1586918, encodeId=52271586918f6, content=<a href='/topic/show?id=e2d3e8130f4' target=_blank style='color:#2F92EE;'>#细菌耐药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78130, encryptionId=e2d3e8130f4, topicName=细菌耐药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=690d17392347, createdName=yilong5287548, createdTime=Wed Feb 16 13:20:35 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193619, encodeId=5487119361908, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dfcf5562063, createdName=ms2000001254384452, createdTime=Tue Feb 15 14:35:01 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193485, encodeId=fec31193485bb, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ae36495381, createdName=ms9000002100948639, createdTime=Tue Feb 15 09:08:36 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193463, encodeId=51dd1193463ec, content=2021年12月患者无明显诱因下出现发热,Tmax, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIrrxxDxnLic8t6EAs38Qfwo6H2h6JMleIgb9OSYf6LMnVDkQEqUXWoSDWboibjhOBI9SJDTXweqQIA/132, createdBy=50aa5321359, createdName=查查佳佳, createdTime=Tue Feb 15 08:07:26 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193455, encodeId=4f9811934552a, content=写得好,知识面广, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89ae6481716, createdName=ms3000000637975859, createdTime=Tue Feb 15 06:38:02 CST 2022, time=2022-02-15, status=1, ipAttribution=)]
    2022-02-15 ms2000001254384452

    学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2069784, encodeId=45782069e84ff, content=<a href='/topic/show?id=c525804035a' target=_blank style='color:#2F92EE;'>#耐药监测#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80403, encryptionId=c525804035a, topicName=耐药监测)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=xinxin088, createdTime=Fri Feb 18 05:20:35 CST 2022, time=2022-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1734467, encodeId=2d991e344672c, content=<a href='/topic/show?id=d4f412668a4' target=_blank style='color:#2F92EE;'>#NET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12668, encryptionId=d4f412668a4, topicName=NET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ea033781210, createdName=canlab, createdTime=Tue Feb 22 00:20:35 CST 2022, time=2022-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1586918, encodeId=52271586918f6, content=<a href='/topic/show?id=e2d3e8130f4' target=_blank style='color:#2F92EE;'>#细菌耐药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78130, encryptionId=e2d3e8130f4, topicName=细菌耐药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=690d17392347, createdName=yilong5287548, createdTime=Wed Feb 16 13:20:35 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193619, encodeId=5487119361908, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dfcf5562063, createdName=ms2000001254384452, createdTime=Tue Feb 15 14:35:01 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193485, encodeId=fec31193485bb, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ae36495381, createdName=ms9000002100948639, createdTime=Tue Feb 15 09:08:36 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193463, encodeId=51dd1193463ec, content=2021年12月患者无明显诱因下出现发热,Tmax, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIrrxxDxnLic8t6EAs38Qfwo6H2h6JMleIgb9OSYf6LMnVDkQEqUXWoSDWboibjhOBI9SJDTXweqQIA/132, createdBy=50aa5321359, createdName=查查佳佳, createdTime=Tue Feb 15 08:07:26 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193455, encodeId=4f9811934552a, content=写得好,知识面广, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89ae6481716, createdName=ms3000000637975859, createdTime=Tue Feb 15 06:38:02 CST 2022, time=2022-02-15, status=1, ipAttribution=)]
    2022-02-15 ms9000002100948639

    学习

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2069784, encodeId=45782069e84ff, content=<a href='/topic/show?id=c525804035a' target=_blank style='color:#2F92EE;'>#耐药监测#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80403, encryptionId=c525804035a, topicName=耐药监测)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=xinxin088, createdTime=Fri Feb 18 05:20:35 CST 2022, time=2022-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1734467, encodeId=2d991e344672c, content=<a href='/topic/show?id=d4f412668a4' target=_blank style='color:#2F92EE;'>#NET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12668, encryptionId=d4f412668a4, topicName=NET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ea033781210, createdName=canlab, createdTime=Tue Feb 22 00:20:35 CST 2022, time=2022-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1586918, encodeId=52271586918f6, content=<a href='/topic/show?id=e2d3e8130f4' target=_blank style='color:#2F92EE;'>#细菌耐药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78130, encryptionId=e2d3e8130f4, topicName=细菌耐药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=690d17392347, createdName=yilong5287548, createdTime=Wed Feb 16 13:20:35 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193619, encodeId=5487119361908, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dfcf5562063, createdName=ms2000001254384452, createdTime=Tue Feb 15 14:35:01 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193485, encodeId=fec31193485bb, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ae36495381, createdName=ms9000002100948639, createdTime=Tue Feb 15 09:08:36 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193463, encodeId=51dd1193463ec, content=2021年12月患者无明显诱因下出现发热,Tmax, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIrrxxDxnLic8t6EAs38Qfwo6H2h6JMleIgb9OSYf6LMnVDkQEqUXWoSDWboibjhOBI9SJDTXweqQIA/132, createdBy=50aa5321359, createdName=查查佳佳, createdTime=Tue Feb 15 08:07:26 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193455, encodeId=4f9811934552a, content=写得好,知识面广, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89ae6481716, createdName=ms3000000637975859, createdTime=Tue Feb 15 06:38:02 CST 2022, time=2022-02-15, status=1, ipAttribution=)]
    2022-02-15 查查佳佳

    2021年12月患者无明显诱因下出现发热,Tmax

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=2069784, encodeId=45782069e84ff, content=<a href='/topic/show?id=c525804035a' target=_blank style='color:#2F92EE;'>#耐药监测#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80403, encryptionId=c525804035a, topicName=耐药监测)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=xinxin088, createdTime=Fri Feb 18 05:20:35 CST 2022, time=2022-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1734467, encodeId=2d991e344672c, content=<a href='/topic/show?id=d4f412668a4' target=_blank style='color:#2F92EE;'>#NET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12668, encryptionId=d4f412668a4, topicName=NET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ea033781210, createdName=canlab, createdTime=Tue Feb 22 00:20:35 CST 2022, time=2022-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1586918, encodeId=52271586918f6, content=<a href='/topic/show?id=e2d3e8130f4' target=_blank style='color:#2F92EE;'>#细菌耐药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78130, encryptionId=e2d3e8130f4, topicName=细菌耐药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=690d17392347, createdName=yilong5287548, createdTime=Wed Feb 16 13:20:35 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193619, encodeId=5487119361908, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dfcf5562063, createdName=ms2000001254384452, createdTime=Tue Feb 15 14:35:01 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193485, encodeId=fec31193485bb, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ae36495381, createdName=ms9000002100948639, createdTime=Tue Feb 15 09:08:36 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193463, encodeId=51dd1193463ec, content=2021年12月患者无明显诱因下出现发热,Tmax, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIrrxxDxnLic8t6EAs38Qfwo6H2h6JMleIgb9OSYf6LMnVDkQEqUXWoSDWboibjhOBI9SJDTXweqQIA/132, createdBy=50aa5321359, createdName=查查佳佳, createdTime=Tue Feb 15 08:07:26 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193455, encodeId=4f9811934552a, content=写得好,知识面广, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89ae6481716, createdName=ms3000000637975859, createdTime=Tue Feb 15 06:38:02 CST 2022, time=2022-02-15, status=1, ipAttribution=)]
    2022-02-15 ms3000000637975859

    写得好,知识面广

    0

相关资讯

Nurs Outlook:护士在加强全球卫生安全方面发挥重要作用

护士必须在推动监测相关研究和政策制定方面发挥领导作用,以加强全球卫生安全。

JNER:中风后监测下肢运动功能的变化

大约三分之二的中风幸存者出现身体机能问题,导致身体活动 (PA) 参与度低。追求体育锻炼的生活方式很重要,因为它可以降低复发性卒中的风险,并且与更好的功能能力、生活质量和整体生活满意度有关。因此,从卒

疫情防控新闻发布会|上海:发热门诊对所有就诊人员核酸检测

2020年5月8日下午2:00,上海举行新闻发布会,邀请市卫生健康委新闻发言人郑锦,市交通委副主任杨小溪,市疫情防控公共卫生专家组成员、复旦大学上海医学院副院长吴凡,市疾控中心传染病防治所所长、主任医

Blood Cancer Journal:一种检测多发性骨髓瘤多种耐药性的新技术

多发性骨髓瘤(MM)是一种无法治愈的终末分化的骨髓浆细胞瘤,作为全球第二大血液系统恶性肿瘤,其5年生存率仅为43%。自1990年以来,它的发病率增加了126%,仅在2018年里就报道了159 985例

Gastroenterology:Barrett食管患者多大年龄时可停止进行内镜监测?

合并症严重程度和性别均显著影响Barrett食管患者停止进行内镜监测的时间

国家医保局:将对药品、耗材价格进行监测和成本调查

近日,国家医保局发布《医疗保障行政执法事项指导目录》(以下简称目录)的通知,通知显示,据国家医保局通知显示,该《目录》已经第36次局长办公会审议通过,要求各地医保局严格遵照执行。